BioE3 advances India’s gene‑editing and cell therapy drive: Minister
New Delhi, March 19 (IANS) Regulatory bodies have issued national guidelines to ensure safe, ethical deployment of CRISPR-based therapies in India, while the BioE3 is accelerating indigenous capacity for cell and gene therapeutics, the government said on Thursday responding to a question on self-reliance in CRISPR and gene editing.